The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 30, Issue 3, 2012, Pages 322-326

  He, Jing ^a   Qiang, Lu ^b   Ding, Yan ^a   Wei, Pan ^b   Li, Yingni ^a   Hua, Hong ^b   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

primary Sj gren's syndrome; Saliva; Type 3 muscarinic acetylcholine receptor

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LA ANTIBODY; MUSCARINIC RECEPTOR TYPE 3 POLYPEPTIDE ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD ANALYSIS; CHINESE; CONTROLLED STUDY; DISEASE DURATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SALIVA ANALYSIS; SALIVA FLOW RATE; SALIVATION; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SOLID PHASE SYNTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; XEROPHTHALMIA; XEROSTOMIA;

ADULT; AGED; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RECEPTORS, MUSCARINIC; SALIVA; SJOGREN'S SYNDROME;

EID: 84864769771     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. FOX RI: Sjögren Syndrome. Lancet 2005; 366: 321-31.
2. ZHANG NZ, SHI QS, YAO QP et al.: Epidemiological studies on primary Sjögren syndrome. Chin J Intern Med 1993; 32: 522-3.
3. BACMAN S, STERIN-BORDA L, CAMUSSO JJ et al.: Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996; 104: 454-9.
4. KOO N-Y, LI J, HWANG S-M et al.: Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjögren's syndrome patients. Rheumatology 2008; 47: 828-33.
5. GAUTAM D, HEARD TS, CUI Y, MILLER G, BLOODWORTH L, WESS J: Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double- knockout mice. Mol Pharmacol 2004; 66: 260-7.
6. WATERMAN SA, GORDON TP, RISCHMUELLER M: Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43: 1647-54.
7. KOVACS L, MARCZINOVITS I, GYORGY A et al.: Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 313-228 in primary Sjögren's syndrome. Rheumatology 2005; 44: 1021-5.
8. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
9. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
11. BJERRUM K, PRAUSE JU: Primary Sjögren's syndrome: a subjective description of the disease. Clin Exp Rheumatol 1990; 8: 283-98.
12. ATINA S, MARIE WH: Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjögren's syndrome. Scand J Rheumatol 2003; 32: 79-82.
13. FOX RI, KONTTINEN Y, FISHER A: Use of muscarinic agonists in the treatment of Sjögren's syndrome. Clin Immunol 2001; 101: 249-63.
14. MANA IIZUKA A, EI W, HIROTO T et al.: Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis, J Autoimmun 2010; 35: 383-9.
15. DIGBY GJ, SHIREY JK, CONN PJ: Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. Mol Biosyst 2010; 6: 1345-54.
16. ZANDBELT M, TE BOOME L, KLASEN I, VAN DE PUTTE L, VAN DEN HOOGEN F: Tear fluid measurement of anti-SS-A and anti-SS-B antibody in anti-SS-A and anti-SS-B seronegative Sjögren's syndrome patients. Clin Exp Rheumatol 2009; 27: 536.